Documents
The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries
22 June 2020
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.
Related
What the data tell us: Projections for the HIV epidemic in western and central Europe and North America in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in the Middle East and North Africa in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in eastern Europe and central Asia in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in Asia and the Pacific in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in western and central Africa in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in eastern and southern Africa in 2030
28 March 2025
U=U can help end HIV stigma and discrimination. Here’s how
27 February 2025
